MDCX vs. SCLX
MDCX (Medicus Pharma Ltd) and SCLX (Scilex Holding Company) are both stocks. Both are in the Healthcare sector — MDCX in Biotechnology, SCLX in Drug Manufacturers - General. Over the past year, MDCX returned -81.97% vs 124.71% for SCLX. At a 0.06 correlation, their price movements are largely independent.
Performance
MDCX vs. SCLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDCX achieves a -70.65% return, which is significantly lower than SCLX's -9.56% return.
MDCX
- 1D
- -1.86%
- 1M
- 49.67%
- YTD
- -70.65%
- 6M
- -71.22%
- 1Y
- -81.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SCLX
- 1D
- -8.03%
- 1M
- 80.58%
- YTD
- -9.56%
- 6M
- -22.68%
- 1Y
- 124.71%
- 3Y*
- -63.15%
- 5Y*
- -49.84%
- 10Y*
- —
MDCX vs. SCLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MDCX Medicus Pharma Ltd | -70.65% | -37.04% | -21.61% |
SCLX Scilex Holding Company | -9.56% | -18.25% | -42.38% |
Correlation
The correlation between MDCX and SCLX is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Nov 14, 2024 | 0.06 |
Fundamentals
MDCX:
-$1.93
SCLX:
-$35.27
MDCX:
$0.00
SCLX:
$30.25M
MDCX:
$0.00
SCLX:
$18.07M
MDCX:
-$36.18M
SCLX:
-$352.83M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDCX vs. SCLX — Risk / Return Rank
MDCX
SCLX
MDCX vs. SCLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medicus Pharma Ltd (MDCX) and Scilex Holding Company (SCLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MDCX | SCLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.65 | ||
| Sortino ratioReturn per unit of downside risk | -3.05 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.25 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 1.56 | -2.46 |
| Martin ratioReturn relative to average drawdown | -1.37 | 2.31 | -3.68 |
Loading charts...
Drawdowns
MDCX vs. SCLX - Drawdown Comparison
The maximum MDCX drawdown since its inception was -96.47%, roughly equal to the maximum SCLX drawdown of -99.23%. Use the drawdown chart below to compare losses from any high point for MDCX and SCLX.
Loading charts...
Drawdown Indicators
| MDCX | SCLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.47% | -99.23% | +2.76% |
Max Drawdown (1Y)Largest decline over 1 year | -91.91% | -80.27% | -11.64% |
Max Drawdown (3Y)Largest decline over 3 years | — | -98.20% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.23% | — |
Current DrawdownCurrent decline from peak | -94.23% | -97.87% | +3.64% |
Average DrawdownAverage peak-to-trough decline | -57.66% | -57.08% | -0.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 59.85% | 54.23% | +5.62% |
Volatility
MDCX vs. SCLX - Volatility Comparison
The current volatility for Medicus Pharma Ltd (MDCX) is 35.89%, while Scilex Holding Company (SCLX) has a volatility of 44.68%. This indicates that MDCX experiences smaller price fluctuations and is considered to be less risky than SCLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDCX | SCLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 35.89% | 44.68% | -8.79% |
Volatility (6M)Calculated over the trailing 6-month period | 119.19% | 75.51% | +43.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 126.68% | 125.36% | +1.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 131.88% | 112.53% | +19.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 131.88% | 109.27% | +22.61% |
Dividends
MDCX vs. SCLX - Dividend Comparison
Neither MDCX nor SCLX has paid dividends to shareholders.
Financials
MDCX vs. SCLX - Financials Comparison
This section allows you to compare key financial metrics between Medicus Pharma Ltd and Scilex Holding Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MDCX and SCLX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SCLX has higher volatility (44.68%) compared to MDCX (35.89%). In terms of maximum drawdown, MDCX dropped -96.47% vs SCLX's -99.23%.
SCLX currently has the higher Sharpe Ratio (1.00 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDCX and SCLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer